Industry players expect more partnerships in the new year between public and the private sector in the healthcare space, which they feel is 'under-invested'

The stock ended 9.02% or 47 points higher on the BSE. The stock has been gaining for the last four days and has risen 11.40% during the period. The stock touched an intra day high of Rs 578 (10.89%) intraday.

The board of directors in its meeting held on Saturday approved raising of funds through issuance of non-convertible debentures or bonds on private placement basis up to an aggregate amount not exceeding Rs 1,800 crore.

India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.

Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.

While the Sensex hit an all-time high of 34,356, Nifty was trading above 10,600 for the first time ever, rising more than 50 points from Friday's close. Of 50 Nifty stocks, 45 were in trading the green.

 The just concluded year, hurt Indian pharma companies in more ways than one

Energy firms gained on higher crude prices as sentiment was upbeat in domestic and global energy stocks with Brent crude hitting its highest level since July 2015 after Saudi Arabia agreed to support the extension of a global oil production cut agreement. While Reliance Industries gained over 1 percent, the ONGC stock rose up to 4 per cent post its Q2 earnings.

The company which started its Indian operations in 2004 is going to launch some of its latest epilepsy and cancer drugs in India.

A number of Indian companies are facing action from the USFDA for failing manufacturing quality standards.